Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
02/2012
02/21/2012CA2478542C Aminoindazole derivatives, their method of preparation and intermediaries of this process as medicines and pharmaceutical compositions containing same
02/21/2012CA2472399C Pharmaceutical compositions comprising valsartan and nep inhibitors
02/21/2012CA2442204C Mixtures of fructose, sucrose and lactose as a low-calorie bulk sweetener with reduced glycemic index
02/21/2012CA2400141C Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and preparation thereof
02/21/2012CA2398940C Methods and compositions using stearoyl-coa desaturase to identify triglyceride reducing therapeutic agents
02/21/2012CA2349760C Bovine cells expressing adeno virus essential functions for propagation of recombinant adenoviral vectors
02/16/2012WO2012021830A1 4 - aminoquinazolin- 2 - yl - 1 - pyrrazole - 4 - carboxylic acid compounds as prolyl hydroxylase inhibitors
02/16/2012WO2012021698A2 Treatment of diabetes with pancreatic endocrine precursor cells
02/16/2012WO2012021647A2 Modulators of nod1 and nod2 signaling, methods of identifying modulators of nod1 and nod2 signaling, and uses thereof
02/16/2012WO2012021287A2 Methods for the treatment and prevention of metabolic disorders
02/16/2012WO2012021249A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of histidyl-trna synthetases
02/16/2012WO2012021247A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-trna synthetases
02/16/2012WO2012021068A1 Composition for treating hyperlipidemia
02/16/2012WO2012021038A2 Composition for preventing and treating diabetes complications including spenceria ramalana extract or fraction thereof as active ingredient
02/16/2012WO2012021035A2 Composition for preventing and treating diabetes complications containing litsea japonica extract or fraction thereof as active ingredient
02/16/2012WO2012021014A2 Composition for preventing or treating diabetes or diabetes complications, containing composite composition of angelicae gigantis radix extract and wild garlic leaves extract as active ingredient
02/16/2012WO2012021013A2 Novel biphenyl compound or pharmaceutically acceptable salt thereof, method for preparing novel biphenyl compound or pharmaceutically acceptable salt thereof, and pharmaceutical composition containing same as active ingredient for preventing or treating diabetes complications
02/16/2012WO2012020956A2 Production method for a functional grain using red-yeast rice
02/16/2012WO2012020845A1 Method of producing pancreatic hormone-producing cells
02/16/2012WO2012020767A1 Pyrroloquinoline quinone gel
02/16/2012WO2012020725A1 Heterocyclic derivative having npy y5 receptor antagonism
02/16/2012WO2012020724A1 Process for preparing aminoadamantyl carbamate derivatives
02/16/2012WO2012020217A1 Amino- imidazolothiadiazoles for use as protein or lipid kinase inhibitors
02/16/2012WO2012020215A1 Amino- imidazolothiadiazoles for use as protein or lipid kinase inhibitors
02/16/2012WO2012020035A1 New azacyclic compounds
02/16/2012WO2012020021A1 Glycyrrhetinic acid amine analogues for use in the treatment of inflammation, infectious diseases, cancer, autoimmune diseases, skin diseases, bone diseases and metabolic diseases
02/16/2012WO2012019966A1 1,4,5,6-tetrahydro-pyrimidin-2-ylamine compounds
02/16/2012WO2012019496A1 C-aryl glucoside derivatives, preparation rpocess and pharmaceutical use thereof
02/16/2012WO2012019479A1 Effective fraction from the fruiting bodies of ganoderma lucidum, extraction method, use and preparation thereof
02/16/2012WO2012019428A1 Benzohydrol derivatives, a preparation process and pharmaceutical use thereof
02/16/2012WO2011138762A3 Cholesterol ester for reducing cholesterol absorption
02/16/2012WO2011126833A3 Anti-inflammatory factors
02/16/2012US20120041524 Compositions for Providing Vitamin D Year Round and Uses Thereof
02/16/2012US20120041176 Ucp4
02/16/2012US20120041069 Sglt2 inhibitor dosage forms
02/16/2012US20120041058 Composition of traditional chinese medicine for reducing blood fat and preparation method thereof
02/16/2012US20120041054 Compositions and methods for the treatment of sepsis and other disorders involving phospholipase a2 induction
02/16/2012US20120041051 Compositions And Methods For Inhibiting Expression Of MIG-12 Gene
02/16/2012US20120041031 Method of activating regulatory t cells with alpha-2b adrenergic receptor agonists
02/16/2012US20120041025 Dihydrolipoic Acid Derivatives Comprising Nitric Oxide and Therapeutic Uses Thereof
02/16/2012US20120041024 Quinolyl amines as kinase inhibitors
02/16/2012US20120041023 Small molecule activators of mitochondrial function
02/16/2012US20120041013 New azacyclic compounds
02/16/2012US20120041012 Substituted spirocyclic amines useful as antidiabetic compounds
02/16/2012US20120041011 Substituted benzofused derivatives and their use as vanilloid receptor ligands
02/16/2012US20120041010 Pharmaceutical combination of (e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl] (3r,5s)-3,5-dihydroxyhept-6-enoic acid and candesartan
02/16/2012US20120041003 Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme
02/16/2012US20120041002 Substituted pyrazolo [1,5-a] pyrimidines as metabotropic glutamate antagonists
02/16/2012US20120040996 3-benzofuranyl-indol-2-one derivatives substituted at the 3 position, preparation thereof, and therapeutic use thereof
02/16/2012US20120040993 Neuroprotective multifunctional compounds and pharmaceutical compositions comprising them
02/16/2012US20120040988 DERIVATIVES OF 6,7-DIHYDRO-3H-OXAZOLO[3,4-a]PYRAZINE-5,8-DIONE
02/16/2012US20120040987 Derivatives of 6-(6-nh-substituted-triazolopyridazine-sulfanyl) benzothiazoles and benzimidazoles, preparation thereof, use thereof as drugs, and use thereof as met inhibitors
02/16/2012US20120040985 Triazole and imidazole derivatives for use as tgr5 agonists in the treatment of diabetes and obesity
02/16/2012US20120040984 Thiadiazole and oxadiazole derivatives, preparation thereof and therapeutic use thereof
02/16/2012US20120040983 Phthalazine Compounds as P38 Map Kinase Modulators and Methods of Use Thereof
02/16/2012US20120040982 Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions
02/16/2012US20120040975 Bridged bicyclic heterocycle derivatives and methods of use thereof
02/16/2012US20120040973 Derivatives of [1,3]oxazin-2-one useful for the treatment of metabolic diseases such as lipid disorders
02/16/2012US20120040970 Intranasal delivery system for dantrolene
02/16/2012US20120040964 N-substituted piperidines and their use as pharmaceuticals
02/16/2012US20120040960 4-azetidinyl-1-phenyl-cyclohexane antagonists of ccr2
02/16/2012US20120040953 Compounds for the Treatment of Metabolic Disorders
02/16/2012US20120040951 Heteroaryl compounds useful as raf kinase inhibitors
02/16/2012US20120040899 Method for Treating Hyperglycemia with GLP-1
02/16/2012US20120040898 Pharmaceutical compositions
02/16/2012US20120040897 Novel derivatives of acyl cyanopyrrolidines
02/16/2012US20120040895 Peptide availability
02/16/2012US20120040894 Mini-Hepcidin Peptides and Methods of Using thereof
02/16/2012US20120040893 Modification of feeding behaviour
02/16/2012US20120040892 Methods and Compositions for the Treatment of Heart Failure and Other Disorders
02/16/2012US20120040886 Analogues of Neuropeptide Y Having Proline Substitution At Position 34
02/16/2012US20120040885 Analogues of Neuropeptide Y Having At Least One Synthetic Amino Acid Substitution
02/16/2012US20120040027 Food or beverage composition comprising unroasted coffee solids
02/16/2012US20120040025 Compositions and Methods for Treating Disorders Associated with Salt or Fluid Retention
02/16/2012US20120040014 LIPID Supplements for Maintaining Health and Treatment of Acute and Chronic Disorders
02/16/2012US20120039997 Methods of treating hypertriglyceridemia
02/16/2012US20120039987 Niosome having metal porphyrin complex embedded therein, process for producing the same and drug with the use thereof
02/16/2012US20120039986 Compositions and methods for sirna inhibition of angiopoietin 1 and 2 and their receptor tie2
02/16/2012US20120039970 Ready-to-use, stable suspension of partially amorphous carotenoid particles
02/16/2012US20120039964 Novel formulations of fat-soluble active ingredients with high bioavailability
02/16/2012US20120039955 Treatment of Diabetes with Pancreatic Endocrine Precursor Cells
02/16/2012US20120039946 Immunopotentiating composition and process for producing same
02/16/2012US20120039929 Novel therapy for lysosomal enzyme deficiencies
02/16/2012US20120039919 Diabetes diagnostic, prophylactic, and therapeutic compositions and methods
02/16/2012US20120039886 Use of an immunoglobulin g (igg) concentrate depleted of anti-a and anti-b antibodies for treating neonatal jaundice caused by maternal-foetal incompatibility with respect to the abo system
02/16/2012US20120039883 Detection and diagnosis of inflammatory disorders
02/16/2012US20120039874 Human monoclonal antibody against a costimulatory signal transduction molecule ailim and pharmaceutical use thereof
02/16/2012US20120039852 Lactobacillus rhamnosus ncc4007, a probiotic mixture and weight control
02/16/2012US20120039843 Conjugates of a polypeptide and an oligosaccharide
02/16/2012US20120039841 T-Helper Cell Type 17 Lineage-Specific Adjuvants, Compositions and Methods
02/16/2012US20120039804 Novel Tricyclic Modulators of Cannabinoid Receptors
02/16/2012US20120038073 Spray drying methods and related compositions
02/16/2012DE102004045186B9 Liposomen, die die intrazelluläre Penetration von Wirkstoffen stimulieren, deren Verwendung zur Herstellung von topischen pharmazeutischen bzw. kosmetischen Zusammensetzungen, die diese Liposomen enthalten sowie ein Screening-Verfahren zum Auffinden von Substanzen zur Stimulierung der intrazellulären Penetration Liposomes, which stimulate the intracellular penetration of active substances, their use for the preparation of topical pharmaceutical and cosmetic compositions containing these liposomes as well as a screening method for finding substances for stimulating the intracellular penetration
02/16/2012CA2807935A1 Method of producing pancreatic hormone-producing cells
02/16/2012CA2807158A1 Treatment of diabetes with pancreatic endocrine precursor cells
02/16/2012CA2807034A1 C-aryl glucoside derivatives, preparation process and pharmaceutical use thereof
02/16/2012CA2806159A1 New azacyclic compounds
02/16/2012CA2805867A1 1,4,5,6-tetrahydro-pyrimidin-2-ylamine compounds
02/15/2012EP2418213A1 Neuromedin u derivative
02/15/2012EP2418203A1 Cyclic compound having substituted phenyl group
1 ... 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 ... 1298